Patients in the immune-tolerant phase of chronic HBV infection should be actively treated with antiviral therapy
-
-
Key words:
- Hepatitis B Virus /
- Hepatitis B, Chronic /
- Immune Tolerance /
- Therapeutics
-
[1] LIU J, WANG J, YAN T, et al. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice[J]. J Viral Hepat, 2019, 26(10): 1170-1177. DOI: 10.1111/jvh.13156. [2] PAN X, CHEN J, ZHOU L, et al. Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus[J]. Sci Rep, 2020, 10(1): 13631. DOI: 10.1038/s41598-020-70644-4. [3] Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007. [4] KENNEDY P, SANDALOVA E, JO J, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B[J]. Gastroenterology, 2012, 143(3): 637-645. DOI: 10.1053/j.gastro.2012.06.009. [5] SETO WK, LO YR, PAWLOTSKY JM, et al. Chronic hepatitis B virus infection[J]. Lancet, 2018, 392(10161): 2313-2324. DOI: 10.1016/S0140-6736(18)31865-8. [6] HE LY, WANG YL, TIAN X, et al. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study[J]. Medicine (Baltimore), 2020, 99(14): e19647. DOI: 10.1097/MD.0000000000019647.
本文二维码
计量
- 文章访问数: 295
- HTML全文浏览量: 64
- PDF下载量: 70
- 被引次数: 0